These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17889122)

  • 21. Acute and chronic rejection after lung transplantation.
    Knoop C; Estenne M
    Semin Respir Crit Care Med; 2006 Oct; 27(5):521-33. PubMed ID: 17072800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Xaubet A; Serrano-Mollar A; Ancochea J
    Expert Opin Pharmacother; 2014 Feb; 15(2):275-81. PubMed ID: 24308635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased lung allograft failure in patients with HLA-specific antibody.
    Girnita AL; McCurry KR; Zeevi A
    Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Poletti V; Ravaglia C; Tomassetti S
    Expert Rev Respir Med; 2014 Oct; 8(5):539-45. PubMed ID: 25113033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renoprotective effects of pirfenidone on chronic renal allograft dysfunction by reducing renal interstitial fibrosis in a rat model.
    Qiu ZZ; He JM; Zhang HX; Yu ZH; Zhang ZW; Zhou H
    Life Sci; 2019 Sep; 233():116666. PubMed ID: 31325427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antirheumatic effect of pirfenidone in a double blind clinical pilot trial in humans.
    Pesce E; Struma E; Giri SN; Margolin SB
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():39-48. PubMed ID: 17564304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary lung transplantation: the UCLA experience.
    Sherman W; Rabkin D; Ross D; Ardehali A;
    Clin Transpl; 2008; ():163-70. PubMed ID: 19708455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pirfenidone: a potential therapy for progressive lung allograft dysfunction?
    Ihle F; von Wulffen W; Neurohr C
    J Heart Lung Transplant; 2013 May; 32(5):574-5. PubMed ID: 23453574
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis].
    Bonella F; Wessendorf TE; Costabel U
    Dtsch Med Wochenschr; 2013 Mar; 138(11):518-23. PubMed ID: 23423955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of topical application of pirfenidone ointment on thermoplasty-induced acute lameness in a double-blind and acute and chronic lameness of musculoskeletal origin in an open multi-centered field trial in horses.
    Giri SN; Margolin SB
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():47-63. PubMed ID: 18426078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary graft dysfunction in lung transplantation.
    Carter YM; Davis RD
    Semin Respir Crit Care Med; 2006 Oct; 27(5):501-7. PubMed ID: 17072798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pirfenidone: a potential therapeutic option in the treatment of liver fibrosis.
    Grizzi F
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):961-2. PubMed ID: 19650793
    [No Abstract]   [Full Text] [Related]  

  • 33. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction.
    Magro CM; Abbas AE; Seilstad K; Pope-Harman AL; Nadasdy T; Ross P
    Hum Immunol; 2006; 67(4-5):274-83. PubMed ID: 16720207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?
    Papiris SA; Kagouridis K; Kolilekas L; Triantafillidou C; Tsangaris I; Manali ED
    Eur Respir J; 2012 Sep; 40(3):794-5. PubMed ID: 22941551
    [No Abstract]   [Full Text] [Related]  

  • 35. Pirfenidone: a potential new therapy for restrictive allograft syndrome?
    Vos R; Verleden SE; Ruttens D; Vandermeulen E; Yserbyt J; Dupont LJ; Van Raemdonck DE; De Raedt N; Gheysens O; De Jong PA; Verleden GM; Vanaudenaerde BM
    Am J Transplant; 2013 Nov; 13(11):3035-40. PubMed ID: 24102752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pirfenidone.
    Lasky J
    IDrugs; 2004 Feb; 7(2):166-72. PubMed ID: 15057662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pirfenidone and chronic progressive obliterative airway disease.
    Dosanjh A
    J Heart Lung Transplant; 2006 Apr; 25(4):490. PubMed ID: 16563985
    [No Abstract]   [Full Text] [Related]  

  • 38. A pilot study in patients with established advanced liver fibrosis using pirfenidone.
    Armendáriz-Borunda J; Islas-Carbajal MC; Meza-García E; Rincón AR; Lucano S; Sandoval AS; Salazar A; Berumen J; Alvarez A; Covarrubias A; Aréchiga G; García L
    Gut; 2006 Nov; 55(11):1663-5. PubMed ID: 17047115
    [No Abstract]   [Full Text] [Related]  

  • 39. Idiopathic pulmonary fibrosis and pirfenidone.
    Collard HR
    Eur Respir J; 2010 Apr; 35(4):728-9. PubMed ID: 20356985
    [No Abstract]   [Full Text] [Related]  

  • 40. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice.
    Kehrer JP; Margolin SB
    Toxicol Lett; 1997 Feb; 90(2-3):125-32. PubMed ID: 9067480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.